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Abstract
The internalization of Borrelia burgdorferi, the causative agent of Lyme disease, by phagocytes is essential for an effective
activation of the immune response to this pathogen. The intracellular, cytosolic receptor Nod2 has been shown to play
varying roles in either enhancing or attenuating inflammation in response to different infectious agents. We examined the
role of Nod2 in responses to B. burgdorferi. In vitro stimulation of Nod2 deficient bone marrow derived macrophages
(BMDM) resulted in decreased induction of multiple cytokines, interferons and interferon regulated genes compared with
wild-type cells. However, B. burgdorferi infection of Nod2 deficient mice resulted in increased rather than decreased arthritis
and carditis compared to control mice. We explored multiple potential mechanisms for the paradoxical response in in vivo
versus in vitro systems and found that prolonged stimulation with a Nod2 ligand, muramyl dipeptide (MDP), resulted in
tolerance to stimulation by B. burgdorferi. This tolerance was lost with stimulation of Nod2 deficient cells that cannot
respond to MDP. Cytokine patterns in the tolerance model closely paralleled cytokine profiles in infected Nod2 deficient
mice. We propose a model where Nod2 has an enhancing role in activating inflammation in early infection, but moderates
inflammation after prolonged exposure to the organism through induction of tolerance.
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Introduction
Lyme disease is an infection caused by a tick-borne spirochete,
Borrelia burgdorferi [1–3]. It is the most common vector-borne
disease in the United States with 29,959 definite cases and 8,509
probable cases reported in the U.S. in 2009 according to the
Centers for Disease Control and Prevention. The clinical
manifestations of Lyme disease most typically begin with a
characteristic skin lesion, erythema migrans, which originates at
the site of the tick bite [1]. Over days to weeks, the organism
spreads from the site of the original tick bite to infect distant skin
sites, the nervous system, the heart and joints. B. burgdorferi causes
both acute and chronic infection, as bacterial infection persists
even after the resolution of symptoms. Arthritis manifests
predominantly in the larger weight-bearing joints and is classified
as chronic inflammatory arthritis.
B. burgdorferi induces early host pro-inflammatory responses
through the activation of Toll-like receptors (TLRs). Of the TLRs,
TLR2 appears to be primarily responsible for induction of
inflammatory modulators in response to B. burgdorferi, which
expresses a high number of lipoproteins [4,5]. Phagocytosis of B.
burgdorferi is required for the complete activation of the inflamma-
tory response [6–9], and several intracellular pathogen recognition
molecules, including nucleotide-binding oligomerization domain
containing 2 (Nod2), have been shown to play a role in
transducing signals downstream of acute B. burgdorferi infection in
vitro [10–12]. However, the role of Nod2 has not previously been
examined in an in vivo model of B. burgdorferi infection.
Murine infection with B. burgdorferi results in the development of
arthritis and carditis in susceptible strains of mice. Mice with B.
burgdorferi induced arthritis or carditis show increases in multiple
inflammatory mediators including tumor necrosis factor alpha
(TNF-a), interleukin 6 (IL-6) and interferon regulated genes such
as, cxcl10 and ifit1 [13–16]. Nod2 has been shown to induce many
of these inflammatory mediators in different model systems [17–
19]. The Nod2 receptor has previously been shown to play a role
in inducing inflammation in other forms of murine arthritis, but
again, its role in B. burgdorferi induced arthritis is unknown [20].
Nod2 is a member of the nucleotide-binding domain (NBD) and
leucine-rich repeat (LRR) or NLR family of cytoplasmic,
pathogen-recognition molecules that is involved in host innate
immune defenses [17,19]. Nod2 recognizes moieties of bacterial
peptidoglycan, specifically muramyl dipeptide (MDP), and signals
for the activation of pro-inflammatory cytokines [21,22]. In animal
models, Nod2 has been shown to be required for the development
of acute, peptidoglycan-induced arthritis [20], and has been shown
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bacterial pathogens [12,17,23–26]. Mutations in human Nod2
have also been linked to the development of Crohn’s disease, a
chronicinflammatorybowel disease[19,27,28].In thislattercase,it
is counterintuitive that loss of function mutations in a molecule that
activates pro-inflammatory pathways can result in the increased
inflammatory conditions seen with Crohn’s disease. While a
number of hypotheses exist to try to explain this dichotomy, there
is still no consensus as to the role of Nod2 in different inflammatory
diseases [17,29–31]. One possible unifying explanation is that
Nod2 may serve different functions in acute versus chronic
infections [32] or in infections with a single agent versus conditions
where multiple factors, genetic and microbial, are present.
Here, we report on our studies of NLR receptors in B. burgdorferi
infection. We will show that, similar to prior reports, NLR
receptors are important for mediating the inflammatory response
to B. burgdorferi in acute in vitro models. However, we find that in
vivo, Nod2 deficient mice demonstrate the opposite phenotype,
where loss of Nod2 results in increased rather than decreased
arthritis. We will present data to explain the discrepancies that are
seen between in vitro and in vivo models of Nod2 involvement in
response to B. burgdorferi and propose a model that integrates our
findings into the understanding of Nod2 function in other systems.
Materials and Methods
Ethics Statement
Animals used in B. burgdorferi infection experiments encounter
minimal discomfort. They are anesthetized with ketamine/
xylazine during needle injections to ensure proper subcutaneous
injection rather than to relieve pain or discomfort from the
injection. The mice developed arthritis, which can be painful and
cannot be relieved due to the nature of our studies that focus on
the development of arthritis. The arthritis that develops does not
impair the animal’s ability to feed or drink and peaks at 4 weeks
and is resolved by 8 weeks. Tufts Medical Center has a fully
approved animal care facility staffed by full-time veterinarians.
Any mouse experiencing distress is identified and, if distress cannot
be relieved, euthanized. The procedure for euthanasia is consistent
with the recommendations of the Panel on Euthanasia of the
American Veterinary Medical Association and approved by the
Tufts Medical Center Institutional Animal Care and Use
Committee. This study was carried out in strict accordance with
the U.S. Public Health Service policy and was approved by the
Tufts University and Tufts Medical Center Institutional Animal
Care and Use Committee (permit number B2010-10). Tufts
University and Tufts Medical Center have an Animal Welfare
Assurance on file with the Office of Laboratory Animal Welfare at
the National Institutes of Health (assurance number A3775-01).
Mouse and Bacterial Strains
C57BL/6 wild type, TLR2 and Nod2 deficient mice were
purchased from Jackson Laboratory. Fully backcrossed Nod1
deficient mice were re-derived in specific pathogen free conditions
at Taconic Farms.
Clonal isolates of an infectious, low passage Borrelia burgdorferi
sensu stricto (strain N40, clone D10E9) were used for all
experiments. B. burgdorferi was cultured in Barbour-Stoenner-
Kelley (BSK)-H medium (Sigma, St. Louis, MO) at 37uCa s
previously described [33].
Ligands and Inhibitors
The Nod2 ligand MDP-LD (N-acetylmuramyl-L-alanyl-D-
isoglutamine) was purchased from Invitrogen and resuspended to
a concentration of 100 mg/ml in endotoxin-free water. ATP
(5 mM) was purchased from Invitrogen. Inhibition of endosomal
acidification was achieved using Concanamycin A (100 ng/ml), an
inhibitor of the V-ATPase, or by monensin (1 mM), an ionophore
antibiotic which acts as a Na+/H+ antiporter; both were
purchased from Sigma and used at previously published
concentrations [10,18]. These were added to cell cultures 30
minutes prior to stimulation with B. burgdorferi [18].
Generation of Bone Marrow Derived Macrophages
Mouse bone marrow derived macrophages (BMDM) were
generated as previously described [7]. Bone marrow cells were
flushed from mouse femurs and tibiae with sterile Dulbecco’s
Modified Eagle Medium (DMEM) and cultured on 100 mm
X15 mm plastic petri dishes for 5–7 days in DMEM media
supplemented with 30% L929 cell conditioned medium, 20% fetal
bovine serum (FBS) and 1% penicillin-streptomycin.
Infection of Bone Marrow Derived Macrophage Cultures
B. burgdorferi were washed three times with DMEM with 10%
FBS, counted and resuspended in the same media. Media from
confluent cultures of BMDM was removed and replaced with the
same media containing B. burgdorferi at various multiplicities of
infection (MOIs). Cells were harvested at various time points by
collecting the cell culture supernatant and then adding TRIzol
(Invitrogen) to the remaining cells.
Activation of Bone Marrow Derived Macrophages
BMDM were treated with IFN-c at 100 ng/ml for 24 hours
prior to subsequent stimulations. This was particularly important
in experiments with MDP pre-treatment at 100 mg/ml, since
exogenous addition of MDP alone does not induce cytokine
secretion in BMDM.
Mouse Infections
Mice were infected with a dose of 10
4 B. burgdorferi by
subcutaneous needle inoculation at 3 to 4 days of age. Infections
of mice were confirmed by cultures of ear punch biopsies. Biopsies
were cultured in BSK-H media containing rifampicin (50 ng/ml)
and phosphomycin (100 ng/ml) and were examined for the
presence of B. burgdorferi by darkfield microscopy as previously
described. Mice were sacrificed between 28 to 30 days (4 weeks)
following infection.
ELISA Measurements
Supernatants were collected from BMDM cultures at 6 hours
post stimulation. Cytokines were measured by ELISA using the
TNF-a, IL-10 (R&D systems), and IL-6 (e-Bioscience) kits
following the manufacturer’s instructions.
Real-time Quantitative (qPCR) Analysis
To perform reverse transcriptase (RT)-qPCR analysis of
transcripts, BMDM cells were collected 6 hours after stimulation
unless otherwise indicated. RNA was extracted using TRIzol
following the manufacturer’s instructions. RNA was resuspended
in water containing RNaseOut (Invitrogen) and contaminating
DNA was removed using the Turbo DNA-free kit (Ambion).
Quality of the RNA was checked by examination of RNA integrity
on formamide gels. cDNA was synthesized from 1 mg of RNA
measured by spectrophotometer using the ImPromII kit (Promega)
following the manufacturer’s instructions. DNA contamination
within the RNA template sample was checked either by use of no
RT controls or using primers spanning introns. For measurements
Role of Nod2 in Lyme Disease
PLoS ONE | www.plosone.org 2 February 2011 | Volume 6 | Issue 2 | e17414of B. burgdorferi DNA in tissues, bladders and hearts were collected,
and total DNA was extracted using the DNeasy Blood and Tissue
Kit (Qiagen).
Quantification of target genes from cDNA or total DNA was
performed by qPCR (iCycler, BioRad) using the iQ SYBR Green
Supermix 2X (Biorad). Each primer was added to a final
concentration to 0.4 nM. qPCR analysis was conducted using
the iCycler machine from Biorad. Cycling parameters were 95uC
for 15 minutes, 40 cycles of 95uC for 30 seconds, 60uC for 30
seconds, and 72uC for 30 seconds, followed by 95uC for 1 minute,
55uC for 1 minute. Melt curve analysis for purity was performed
on each sample by performing 80 cycles of increasing temperature
for 10 seconds each beginning at 55uC. Specificity of amplicons
was checked by melt curve analysis and gel electrophoresis. For
analysis of recA, ospA, and nidogen, the 60uC annealing step was
increased to 62uC. Primers used in qPCR analysis of murine tnf-a,
il-6, il-1b, il-10, ifn-a universal primers, cxcl10, ifit1, igtp, mBD4,
mBD14, b-actin, nidogen, and the Borrelia recA were published
previously and/or are listed in Table 1. All samples for each
biological replicate were run in duplicates and checked for intra-
run variation and, if needed, analyzed again. Whenever possible,
different genes/transcripts were analyzed in the same run to avoid
inter-run variations. b-actin was analyzed for every run for all
samples tested, as a positive control and inter-run calibrator. The
number of ospA, recA and nidogen gene copies was quantified using
standard curves created using qPCR products amplified from B.
burgdorferi and murine genomic DNA. Cytokine and b-actin gene
expression was normalized from cDNA using the
DDCt method,
where the amount of target, normalized to an endogenous
reference and relative to a calibrator, is given by 2
2DDCt, where
Ct is the cycle number of the detection threshold. All analyses and
calculations were performed using the iCycler software.
Quantification of Inflammation
Following euthanasia, each ankle was measured 3 times, and the
average of each measurement was determined. For histological
staining, tissues were fixed in Bouin’s solution for 1 week, and then
the hind left leg was skinned, cut in half longitudinally, decalcified,
and embedded in paraffin. Sections were then obtained and the
slides were stained with hematoxylin and eosin (H&E) by the
Rodent Histopathology Core at Harvard Medical School. The
slides were then blindly scored for inflammation on a scale of 1 to
3, with a score of 1 representing the least amount of inflammation
and a score of 3 representing the greatest amount of inflammation.
Statistics
For ELISA and qPCR, the mean percentage of cytokine
expression relative to the control is reported, with statistical
significance determined by Mann-Whitney U analysis. Studies of
inflammation in mouse tissue for which data is reported in discrete
increments were analyzed by Fisher’s exact test. Differences in
mouse joint swelling were analyzed by the Mann-Whitney U test.
Results
Intracellular Activation of Pro-Inflammatory Cytokines Is
Not Solely Dependent on TLR2
It has previously been shown that internalization of B. burgdorferi
and endosomal acidification are important steps in generating
innate immune responses to the pathogen in human macrophages
and human macrophage cell lines, as inhibition of endosomal
acidification decreased pro-inflammatory cytokine secretion, such
as IL-6 secretion [6–8]. To confirm that BMDM also require
endosomal acidification and maturation to engage innate immune
responses to B. burgdorferi, prior to stimulation with live B.
burgdorferi, we treated BMDM with inhibitors of endosomal
acidification such as concanamycin A, an inhibitor of the v-
ATPase, or monensin, a sodium ionophore which inhibits
acidification of the endosome via the Na
+/K
+ pump. Cell culture
supernatants were harvested after 6 hours of incubation and
protein levels of secreted cytokines were determined by ELISA.
Concanamycin and monensin decreased induction of IL-6 by 76%
and 90% respectively (Figure 1A). In contrast to previously
published results of the effects of concanamycin and monensin on
TNF-a induction by B. burgdorferi in U937 human macrophages,
where induction of TNF-a was not significantly dependent on
acidification, concanamycin and monensin inhibited TNF-a
induction from BMDM by 68% and 80% respectively. To ensure
that the effects of the inhibitors were not due to generalized toxic
effects, we stimulated BMDM with lipopolysaccharide (LPS) in the
presence or absence of the inhibitors. Although the LPS receptor,
TLR4, has been shown to signal from the endolysosome for type I
interferons, endosomal acidification does not affect LPS-induced
secretion of cytokines such as TNF-a, which occurs from TLR4
signaling at the plasma membrane [34]. We found that none of the
inhibitors substantially affected TNF-a responses to LPS
(Figure 1B), suggesting the inhibitors do not have unexpected
Table 1. Primer sequences used in qPCR analysis.
Primer Sequence Reference
tnf-a F: 59-ATGAGCACAGAAAGCATGATC-39 [16]
R: 59-TACAGGCTTGTCACTCGAATT-39
il-6 F: 59-GACTTCACAGAGGATACCAC-39 [7]
R: 59-TATCCAGTTTGGTAGCATCC-39
il-1b F: 59-CAGGATGAGGACATGAGCACC-39 [7]
R: 59-CTCTGCAGACTCAAACTCCAC-39




F: 59- ATGGCTAGRCTCTGTGCTTTCCT-39 [69]
R: 59-AGGGCTCTCCAGAYTTCTGCTCTG-39
cxcl10 F: 59- GAAATCATCCCTGCGAGCCTATCC-39 [13,14]
R: 59-GCAATTAGGACTAGCCATCCACTGGG-39
ifit1 F: 59- GTCAACTGTGAGTGCTTCCATCC-39 [13,14]
R: 59- TCAGGGCAGAAAAGTCAAGGC-39
igtp F: 59-TAGAGCAGACCCACAGAGTTCAGG-39 [13,14]
R: 59-CAGCAGTCATAGATTTAGACCACGG-39
mBD4 F: 59- AACATGCATGACCAATGGAG-39 [70]
R: 59- TCATCTTGCTGGTTCTTCATCT-39
mBD14 F: 59- GTATTCCTCATCTTGTTCTTGG-39 [51]
R: 59- AAGTACAGCACACCGGCCAC-39
b-actin F: 59- GTGCGTGACATCAAAGAGAAGC-39 [16]
R: 59- GATGCCACAGGATTCCATACCC-39
recA F: 59-GTGGATCTATTGTATTAGATGAGGCTCTCG-39 [15,16]
R: 59- GCCAAAGTTCTGCAACATTAACACCTAAAG-39
ospA F: 59- GCAACAGTAGACAAGCTTGAGC-39
R: 59- GTGTGGTTTGACCTAGATCGTCA-39
nidogen F: 59-CCAGCCACAGAATACCATCC-39 [15]
R: 59-GGACATACTCTGCTGCCATC-39
doi:10.1371/journal.pone.0017414.t001
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induction.
Having confirmed the requirement for internalization and
endosomal maturation in activating murine BMDM responses to
B. burgdorferi, we next sought to determine whether TLR2 signaling
accounts for the entirety of this response. TLR2 is a major innate
immune receptor which mediates responses to B. burgdorferi and
signals from within the phagolysosome in response to B. burgdorferi
in human macrophages [35]. To determine if TLR2 is the only
intracellular signaling molecule that activates pro-inflammatory
pathways in BMDM in response to B. burgdorferi, we treated TLR2
deficient BMDM with concanamycin A or sham. B. burgdorferi
(MOI=10) was then added to the treated cells. ELISAs performed
on supernatants collected after 6 hours of incubation showed that
the addition of concanamycin A to the TLR2 deficient cells
resulted in a further decrease in the secretion of TNF-a by 30% in
comparison to TLR2 deficient cells not treated with concanamy-
cin (Figure 2). This suggests that intracellular receptors other than
TLR2 also contribute to TNF-a induction in response to B.
burgdorferi.
NLRs That Activate Caspase-1 Are Not Activated by the
Presence of B. burgdorferi in BMDM
We were interested in identifying other molecules that could be
involved in inducing pro-inflammatory responses from sub-cellular
compartments. Candidates included intracellular signaling TLRs
such as TLR 7, 8 and 9 and cytosolic receptors from the NLR
family. Previous studies have shown that TLR9 does not play a
role in the induction of a pro-inflammatory cytokine response in
BMDM by B. burgdorferi [7]. While TLR7/8 has been shown to
activate interferons in response to B. burgdorferi, it has not been
shown to have a role in activating inflammatory cytokines such as
TNF-a [36]. As such, we chose to focus on the NLR family of
proteins. While NLR receptors are cytosolic receptors, activation
of these receptors is often dependent upon the processing of
ligands in endosomes with subsequent sampling of these ligands
through poorly understood mechanisms [19]. Of NLRs whose
function has been identified, the majority participates in the
activation of caspase-1 and cleaves pro-IL1b into mature IL-1b via
the inflammasome complex [37,38]. Stimulating BMDM with B.
burgdorferi resulted in an increase in IL-1b transcripts (data not
shown) [7], but no increase in secreted IL-1b suggesting that the Figure 1. Endosomal processing of B. burgdorferi is important
for cytokine induction in BMDM. A) Murine bone marrow derived
macrophages (BMDM) were incubated with B. burgdorferi at an MOI 10
for 6 hours and supernatants were collected. Endosomal acidification
inhibitors concanamycin A (100 ng/ml) and monensin (1 mM) were
added 30 minutes prior to stimulation. Cytokine levels in BMDM
supernatants were measured by ELISA. Control cells secreted a mean of
3.95 ng/ml of TNF-a and 3.78 ng/ml of IL-6. Concanamycin treated cells
secreted a mean of 1.22 ng/ml of TNF-a and 1.35 ng/ml of IL-6, and
monensin treated cells secreted a mean of 1.06 ng/ml of TNF-a and
0.76 ng/ml of IL-6. Bars represent mean percent change in protein
levels 6 s.e.m. of three independent experiments. Values for control
cells (Ctrl) for each experiment were normalized to 100% and other
values are shown relative to Ctrl. Because of the normalization, the
s.e.m. for Ctrl is zero and no error bars are visible,* p,0.05. B) BMDM
were stimulated for 6 hours with 5 ng/ml of LPS in the presence or
absence of concanamycin A (100 ng/ml) or monensin (1 mM). Super-
natants were collected and TNF-a protein was measured by ELISA. Bars
represent mean percent change in protein levels 6 s.e.m. of three
independent experiments. Values for Control cells (Ctrl) for each
experiment were normalized to 100% and other values are shown
relative to Ctrl. Because of the normalization, the s.e.m. for Ctrl is zero
and no error bars are visible, * p,0.05.
doi:10.1371/journal.pone.0017414.g001 Figure 2. TLR2 independent intracellular signaling plays a role
in the host response to B. burgdorferi signaling. BMDM from wild
type and TLR2 deficient mice were stimulated with B. burgdorferi (MOI
10) for 6 hours and supernatants were collected. Concanamycin A
(100 ng/ml) was added 30 minutes prior to stimulation. Cytokine levels
in supernatants were measured by ELISA. Bars represent mean percent
change in protein levels 6 s.e.m. of three independent experiments.
Wild type cells secreted a mean of 3.51 ng/ml, TLR2 deficient cells a
mean of 1.65 ng/ml, and TLR2 deficient concanamycin treated cells a
mean of 0.5 ng/ml of TNF-a. Bars represent mean percent change in
protein levels 6 s.e.m. of three independent experiments. Values for
wild type cells (B6) for each experiment were normalized to 100% and
other values are shown relative to B6. Because of the normalization, the
s.e.m. for B6 is zero and no error bars are visible, * p,0.05.
doi:10.1371/journal.pone.0017414.g002
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does not directly activate caspase-1 to cleave pro IL-1b (Figure 3).
The caspase-1 inflammasome can also be activated by exogenous
‘‘danger’’ signals such as ATP [37,38], and the addition of ATP
with B. burgdorferi did result in secretion of IL-1b into cell culture
supernatants. In the presence of both B. burgdorferi and exogenous
ATP, treatment with concanamycin A prior to B. burgdorferi
stimulation reduced the amount of pro-IL1b transcript and IL-1b
secretion, suggesting that signaling and activation of pro-IL1b
through other receptors was dependent on endosomal maturation
and intracellular signaling (Figure 3). Thus, despite the fact that B.
burgdorferi expresses flagellin, which is a potential ligand for NLR
members such as Ipaf-1 (Nlrc4) and Naip-5 [39–43], which
activate capase-1 and convert pro-IL-1b into secreted, mature IL-
1b, the organism is not able to induce secretion of IL-1b from
BMDM in the absence of exogenous ATP. This suggests that B.
burgdorferi either does not contain the necessary ligands or does not
possess the necessary mechanisms to make those ligands available
to NLRs that activate the inflammasome, which is consistent with
previous observations that caspase-1 is not required for control of
murine borreliosis [44].
Nod2 Is Involved in Transducing Inflammatory Signals
Downstream of B. burgdorferi in a Model of Acute
Infection in Vitro
NLR family members that activate pathways other than the
inflammasome include Nod1 and Nod2, both of which signal
through the kinase Rip2 for the activation of NF-kB and MAPKs
[19,38]. To determine whether Nod1 or Nod2 might be involved
in responses to B. burgdorferi, we stimulated wild type and Rip2
deficient BMDM with B. burgdorferi. Rip2 deficient cells showed a
34% decrease in TNF-a secretion by ELISA compared to wild-
type cells (data not shown). Because both Nod1 and Nod2 utilize
Rip2, we next sought to determine whether either Nod1 or Nod2
(or both) were involved in cellular responses to B. burgdorferi. Nod1
and Nod2 deficient macrophages were stimulated with B.
burgdorferi. Examination of mRNA transcripts for pro-IL1b, IL-6
and TNF-a after 6 hrs of incubation with B. burgdorferi showed
decreases of 60–75% in Nod1 and Nod2 deficient macrophages
compared to wild type (Figure 4). However, when cell culture
supernatants were examined by ELISA, only Nod2 deficient cells
showed a significant decrease in TNF-a protein levels (Figure 4) or
IL-6 protein levels (Figure 5 and data not shown) in comparison
with the wild type. Thus, it seems unlikely that Nod1 plays an
important role in B. burgdorferi signaling, which is consistent with
previous observations that Nod1 is not involved in immune
response activation downstream of B. burgdorferi [12].
We subsequently focused our efforts on understanding Nod2
mediated cytokine responses downstream of B. burgdorferi. Nod2
deficient cells consistently showed a decrease in protein levels of
TNF-a at different MOIs of B. burgdorferi (Figure 5). In contrast,
the decrease in IL-6 production was statistically significant only at
the lowest MOI tested, MOI=1, which showed a 65% decrease in
Nod2 deficient cells.
We also examined the effects of Nod2 deficiency on induction of
type I interferon (IFN) and IFN- responsive genes, which have
previously been shown to be important in B. burgdorferi infection
and are dependent on internalization of the bacterium
[9,13,14,36]. Using reverse transcription (RT) quantitative real
time PCR-(qPCR), we were able to show that B. burgdorferi
induction of IFN-a in BMDM was decreased by 85% in
Nod2 deficient BMDM when compared to wild-type BMDM
(Figure 6).
We were not able to detect activation of IFN-b in response to B.
burgdorferi and therefore could not address Nod2 involvement in
IFN-b activation (data not shown). However, we did observe a
Nod2 dependence on B. burgdorferi activation of the IFN responsive
gene cxcl10 from BMDM but not the genes ifit1 and igtp (Figure 6).
Nod2 deficiency reduced cxcl10 induction by 60% compared to
the wild type.
Nod2 Deficiency Does Not Have a Significant Effect on
Control of B. burgdorferi Load in Vivo
To address the role of Nod2 in B. burgdorferi infection in vivo,
wild type C57BL/6 and Nod2 deficient mice were subcutane-
ously infected with the spirochetes. The C57BL/6 genetic
background is known to be resistant to B. burgdorferi induced
arthritis. However, young mice of all species develop more severe
arthritis than older mice and even young mice of the C57BL/6
background will develop detectable arthritis. The infant mouse
model has been previously used to study other genetic knockout
mice on a C57BL/6 background [45]. Age matched wild type
and Nod2 deficient mice were infected with B. burgdorferi by
subcutaneous injection. Mice were sacrificed at 4 weeks post-
infection and we examined the numbers of B. burgdorferi in heart
and bladder tissue by qPCR by measuring copies of B. burgdorferi
recA (data not shown) and ospA (Figure 7) relative to mouse
nidogen. Despite the immaturity of the immune system at the time
of infection, the infection of mice with B. burgdorferi at a young
age did not affect the bacterial burden in these mice when
sampled at 3–4 weeks of age compared to mice infected as adults
in previous studies (data not shown) [15]. Our analysis of
bacterial burden showed a median decrease from 1190 copies of
ospA in wild type mouse bladders down to 526 copies in Nod2
deficient bladders and from 11,550 copies in wild type hearts
down to 4,475 copies in Nod2 deficient hearts (p=0.0335 and
0.0155) (Figure 7). This suggests that Nod2 does not play a major
role in reducing bacterial burden and may, in fact, hinder
control of infection.
Figure 3. NLRs that activate caspase-1 do not signal in
response to B. burgdorferi ligands. BMDM were stimulated with B.
burgdorferi (MOI 10) for 6 hours. In designated samples, 5 mM ATP was
added for the last 2 hours of incubation to activate the caspase-1
inflammasome and induce IL-1b secretion. Concanamycin A (100 ng/
ml) was added 30 minutes prior to stimulation. Cytokine levels in
supernatants were measured by ELISA. Shown is 1 representative
experiment from 3 independent experiments. Bars represent the mean
secretion of IL-1b in pg/ml 6 SD of triplicates in the experiment,
*p,0.05.
doi:10.1371/journal.pone.0017414.g003
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Inflammation in Response to B. burgdorferi Infection in
Vivo
We determined the effects of Nod2 deficiency on B. burgdorferi-
induced arthritis and inflammation by characterizing joint
swelling in infected mice using both caliper measurements as
well as histological scoring by blinded investigators. B. burgdorferi
infected Nod2 deficient mice showed increased swelling of the
tibiotarsal joint compared with wild-type control (p=0.039)
(Figure 8A, B, C). This was consistent with histological grading
which revealed significantly increased inflammation in the joints
of Nod2 deficient mice infected with B. burgdorferi (p=0.045). An
increase in inflammation was further confirmed by measur-
ing the levels of IL-6 mRNA transcripts in infected mouse
joints. Mouse il-6 transcripts were increased by 86% in Nod2
deficient animals compared with wild-type transcripts
(p=0.0127) (Figure 8E). tnf-a transcripts were not detectable
in the joints of either wild type or Nod2 deficient mice (data not
shown).
We also examined the effect of the Nod2 deficiency on carditis
in response to B. burgdorferi. Nod2 deficient mice showed an
increase in inflammation by histological scoring in cardiac tissue
(p=0.028) (Figure 8D). Taken together, these results appear to be
inconsistent with in vitro models showing a role for Nod2 in
inducing inflammatory responses to B. burgdorferi and instead
suggest that Nod2 may have a role in reducing inflammation.
Nod2 Does Not Control Inflammation through Induction
of IL-10 in a Mouse Model of B. burgdorferi-Induced
Arthritis
We sought to determine the mechanism(s) by which Nod2
signaling could attenuate the inflammatory response to B.
burgdorferi. Several studies have tried to explain how Nod2 ‘‘loss
of function’’ mutations contribute to the development of human
Crohn’s disease, a chronic inflammatory disorder. Several possible
mechanisms have been proposed to explain how loss of Nod2
signaling could result in increased inflammation. One possible
mechanism is that Nod2 may be important in the induction of the
Figure 4. Nod2 but not Nod1 is involved in activating inflammatory responses downstream of B. burgdorferi. BMDM from wild type (B6)
and Nod2 deficient mice were stimulated with B. burgdorferi at MOI 10 for 6 hours. Cytokine expression was measured by RT-qPCR for Nod2 (A) and
Nod1 (C). Values represent mean expression of cytokines relative to control cells 6 s.e.m. of three independent experiments. TNF-a protein levels in
supernatants were measured by ELISA for Nod2 (B) and Nod1 (D). For each experiment the control value was set at 100%. Bars represent mean
percent secretion relative to control cells 6 s.e.m. of three independent experiments. Values for wild type (B6) cells for each experiment were
normalized to 100% and other values are shown relative to B6. Because of the normalization, the s.e.m. for B6 is zero and no error bars are visible,
*p ,0.05. Wild type cells secreted a mean of 3.51 ng/ml of TNF-a and Nod2 deficient cells secreted a mean of 2.35 ng/ml of TNF-a. In Nod1
experiments, wild type cells secreted a mean of 3.95 ng/ml and Nod1 deficient cells secreted a mean of 3.54 ng/ml of TNF-a.
doi:10.1371/journal.pone.0017414.g004
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human Crohn’s disease associated ‘‘loss-of-function’’ mutations in
Nod2 show reduced transcription of IL-10 in response to bacteria
[46–48]. Pertaining to B. burgdorferi specifically, it has also been
shown that IL-10 deficient mice exhibit an increase in inflamma-
tion of the joints in response to B. burgdorferi infection in
comparison to wild type mice [49]. However, in vitro stimulation
of wild type and Nod2 deficient BMDM with B. burgdorferi results
in a slight increase instead of decrease in il-10 transcripts
(Figure 9A) and secretion (Figure 9B) in Nod2 deficient BMDM
compared to wild type cells, suggesting that a direct role of Nod2
on IL-10 transcript and protein secretion does not explain the
increase in inflammation in Nod2 deficient mice. Similarly,
transcripts for il-10 in joint tissue from wild-type and Nod2
deficient mice infected with B. burgdorferi did not differ significantly
(Figure 9C).
Nod2 May Control Bacterial Load but Not Inflammatory
Responses to B. burgdorferi through the Induction of
Defensins
Another mechanism by which Nod2 has been shown to affect
inflammation is through the control of antimicrobial peptide
production and reduction of bacterial numbers. Given that B.
burgdorferi numbers are lower in the Nod2 deficient mice, this did
not seem like a likely explanation for the results in our model.
However, to confirm this, we examined the effects of the Nod2
deficiency on defensin induction by B. burgdorferi. Nod2 has been
shown to induce alpha defensins in the intestine, as well as human
beta defensin 2 and mouse beta defensin 14 in epithelial cells
[17,50–52]. The most common antimicrobial peptides in articular
joints include cathelicidin LL37, which is not known to be
regulated by Nod2, and human beta defensins 2 and 3 [which
correspond to mouse beta defensins (BD) 4 and 14 respectively]
[53]. We measured transcripts for murine BD4 and BD14 from
inflamed joints. We were not able to detect any induction in mBD4
in either wild type or Nod2 deficient joints of B. burgdorferi infected
mice (data not shown). mBD14 was detectable in arthritic joints of
both wild type and Nod2 deficient mice. However, in contrast to
studies in the Crohn’s model, Nod2 deficient mice showed higher
levels of transcription of mBD14 (5 fold higher) in comparison to
wild type mice when infected with B. burgdorferi (Figure 9D). Thus,
it does not appear that loss of bacterial control due to a decrease in
defensins is the mechanism by which Nod2 deficient mice have
increased B. burgdorferi-induced arthritis.
Sustained Stimulation of Nod2 Results in the
Development of Tolerance to B. burgdorferi
Previous studies have shown that cells that undergo prolonged
stimulation of Nod2, mimicking prolonged infection, no longer
respond to subsequent stimulation by bacterial ligands, such as
LPS, thus becoming tolerant to those stimuli [32,54]. We wanted
to investigate whether sustained stimulation of Nod2 in vitro would
decrease the pro-inflammatory response to B. burgdorferi through
the induction of tolerance. We stimulated activated BMDM with
the Nod2 ligand, MDP, at 100 mg/ml or control for 24 hours. We
selected this time point because it has previously been established
that cells treated with MDP for 24 hours become tolerant to
further MDP or TLR stimulus [32]. In our experiments, sustained
exposure to MDP resulted in a 40% and 75% decrease in secretion
of TNF-a and IL-6 respectively in response to B. burgdorferi
compared to cells not treated with MDP (p=0.037, Figure 10A,
B). However, in Nod2 deficient cells, prolonged exposure to MDP
did not significantly affect levels of protein secretion in response to
B. burgdorferi when compared to wild type cells. Of note, the levels
of il-10 transcripts in Nod2 deficient cells were elevated in
comparison to wild type levels in MDP pre-treated samples, again
suggesting that a decrease in IL-10 is not the mechanism for
increased inflammation in Nod2 deficient cells (Figure 10C). We
also observed greater expression of ifn-a and cxcl10 transcripts by
RT-qPCR in Nod2 deficient cells treated with MDP compared
with MDP treated wild type cells (Figure 11A, B). However, ifit1
Figure 5. Nod2 mediates the activation of cytokines in
response to B. burgdorferi. BMDM from wild type (B6) and Nod2
deficient mice were stimulated with B. burgdorferi at the designated
MOIs for 6 hours. Cytokine levels in supernatants were measures by
ELISA; bars represent mean percent change 6 s.e.m. of three
independent experiments. Values for wild type (B6) cells for each
experiment were normalized to 100% and other values are shown
relative to B6. Because of the normalization, the s.e.m. for B6 is zero and
no error bars are visible, * p,0.05. Raw data for each of the conditions
showed that wild type cells secreted a mean of 6.34, 3.51 and 1.8 ng/ml
of TNF-a at MOIs of 100, 10 and 1 respectively, while Nod2 deficient
cells secreted a mean of 3.52, 2.35 and 1.3 ng/ml at the same MOIs. For
IL-6, wild type cells secreted 1.6 ng/ml of IL-6 for MOI 1, while Nod2
deficient cells secreted a mean of 0.58 ng/ml for IL-6 for MOI 1.
doi:10.1371/journal.pone.0017414.g005
Figure 6. Nod2 mediates the activation of a subset of
interferon and interferon responsive genes upon B. burgdorferi
stimulation. Activated BMDM from wild type (B6) and Nod2 deficient
mice were infected with B. burgdorferi at MOI 10, cells were washed in
DMEM containing 10% FBS and fresh media was added. Cells were
collected 16 hours post-infection for ifn-a and 6 hours post-infection for
cxcl10, ifit1 and igtp. mRNA expression was measured by RT-qPCR.
Values represent mean expression of cytokines relative to control cells
6 s.e.m. of three independent experiments. Values for wild type (B6)
cells for each experiment were normalized to 1 and other values are
shown relative to B6. Because of the normalization, the s.e.m. for B6 is
zero and no error bars are visible, * p,0.05.
doi:10.1371/journal.pone.0017414.g006
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mice were injected subcutaneously with B. burgdorferi at 1610
4 cells. Mice were sacrificed at 4 weeks post-infection. Bacterial loads in bladders (A)o r
hearts (B) were quantified by quantitative RT-qPCR for the bacterial ospA gene and normalized to copies of mouse nidogen. Values represent relative
expression 6 s.e.m. of three independent experiments, * p,0.05.
doi:10.1371/journal.pone.0017414.g007
Figure 8. Nod2 deficient mice exhibit increased arthritis and carditis with B. burgdorferi infection. A) Three or four day old wild type (B6)
and Nod2 deficient mice were injected subcutaneously with B. burgdorferi at 1610
4 cells. Mice were sacrificed at 4 weeks post-infection. Shown are
caliper measurements of joint thickness in millimeters at time of sacrifice. B) Joints from mice infected in 3 independent experiments were sectioned
and stained with H&E and scored blindly by a pathologist for inflammation using a scale of 0-normal, 1- mild, 2-moderate, or 3-severe inflammation.
Horizontal lines on the graphs represent median values for the group. C) Pictured are representative images of the tibiotarsal joints from an infected
wild type and a Nod2 deficient mouse infected with B. burgdorferi. In the Nod2 deficient mice, there is severe inflammation with destruction of the
cartilage and thickened synovium. The wild type mouse shows minimal inflammation. D) Hearts from infected mice were sectioned and stained with
H&E and scored blindly by a pathologist with a score of 0-normal, 1- mild, 2-moderate, or 3-severe inflammation. Horizontal lines on the graphs
represent median values for the group. Significance was calculated using Fisher’s exact test. E) Levels of il-6 transcript were measured by RT-qPCR
from joint tissue in wild type and Nod2 deficient mice. The lowest value in the group was arbitrarily set to a value of 1 and all other values are shown
in reference to that value using the 2
-DDCt method after normalization for the value of nidogen.
doi:10.1371/journal.pone.0017414.g008
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(Figure 6), did not show a decrease in expression upon MDP
stimulation of wild type cells. Rather, we observed a synergistic
effect of B. burgdorferi and MDP stimulation on ifit1 and igtp
induction in wild type cells that was, as expected, absent in Nod2
deficient cells (Figure 11C, D). These data suggest that prolonged
exposure to the Nod2 ligand MDP in vitro, results in suppression of
pro-inflammatory responses to B. burgdorferi and reverses the
phenotype seen in cells immediately infected with B. burgdorferi
where Nod2 appears to play a stimulatory role. The results of these
in vitro tolerance experiments parallel the IL-6 responses seen in the
in vivo experiments, where levels are increased in Nod2 deficient
mice compared with levels in wild type mice.
Discussion
Infection with B. burgdorferi results in the induction of numerous
pro-inflammatory cytokines which are responsible for much of the
pathology related to infection. While activation of TLR2 has been
showntoaccountforamajorityofthepro-inflammatoryresponseto
B. burgdorferi, prior reports have also suggested a role for Nod
receptors [11,12]. However, all of the prior reports have studied the
role of Nod2 in regulating the immune response to B. burgdorferi in in
vitro models only. Our data with BMDM supports prior reports
using microglia, astrocytes and peripheral blood mononuclear cells,
showing that the NLR family receptors, and Nod2 specifically, are
involved in in vitro inflammatory responses to B. burgdorferi [11,12].
WefoundthatNod2mediatesinductionofpro-IL-1b,TNF-a,IL-6,
IFN-a and CXCL10 in response to B. burgdorferi in BMDM in vitro.
However, our results with an in vivo model of B. burgdorferi infection
revealedtwoimportantfindings.First,Nod2 doesnotappeartoplay
an important role inthe controlof B. burgdorferi infection inmiceand
in fact,may hinder control. Second, although Nod2 is demonstrably
involved in the induction of inflammatory mediators in in vitro
models of B. burgdorferi stimulation, Nod2 appears to have the
opposite effect in infected Nod2 mutant mice and is involved in
suppressing inflammatory responses during long-term infection
through mechanisms of tolerance.
Figure 9. IL-10 and beta-defensin deficiency are not responsible for increased inflammation in joints and hearts of B. burgdorferi
infected Nod2 deficient mice. A) BMDM from wild type (B6) and Nod2 deficient mice were stimulated with B. burgdorferi at MOI 10 for 6 hours.
mRNA expression for il-10 was measured by RT-qPCR. Values represent relative expression 6 s.e.m. of three independent experiments, * p,0.05. B)
IL-10 levels in the culture supernatant were measured by ELISA. For each experiment, the control value was set at 100%. Bars represent mean percent
secretion relative to control cells 6 s.e.m. of three independent experiments. Values for wild type (B6) cells for each experiment were normalized to
100% and other values are shown relative to B6. Because of the normalization, the s.e.m. for B6 is zero and no error bars are visible, * p,0.05. Wild
type cells secreted a mean of 80 pg/ml and Nod2 deficient cells a mean of 310 pg/ml. C) Three or four day old wild type (B6) and Nod2 deficient mice
were subcutaneously injected with B. burgdorferi at 1610
4 cells. Mice were sacrificed at 4 weeks post-infection and joints were collected and frozen in
RNAlater. RNA from joints was isolated by grinding in TRIzol. Transcripts from joints were assessed by RT-qPCR for il-10 and mBD14 (D). Horizontal
lines represent the median values.
doi:10.1371/journal.pone.0017414.g009
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mutations in the LRR ligand recognition domains of Nod2 from
human donors, have been associated with a loss in pro-
inflammatory signaling, traditionally measured by a decrease in
NF-kB activation, MAPK signaling and pro-inflammatory cyto-
kine secretion [17,55]. Thus, in vitro data from other model systems
demonstrating a role for Nod2 has been consistent with prior
observations with B. burgdorferi [17,25,55–57].
In other in vivo animal models of inflammation where Nod2
deficient mice have been studied, the role of Nod2 deficiency has
varied, with some models showing deficient mice having increased
inflammation, e.g. ovalbumin antigen-specific induced colitis [58]
or Helicobacter hepatics induced inflammation [59]), and other
models showing deficient mice having decreased inflammation
(e.g. the Salmonella model of colitis and infection models including
Listeria, Staphylococcus and Legionella [17,57,60,61]). Loss of Nod2
function in B. burgdorferi infected mice results in increased, rather
than decreased, inflammation in the heart and affected joints as
confirmed by both histology and measurement of cytokine
expression in joint tissue. Similar discrepancies between in vitro
and in vivo studies have previously been reported in MyD88, CD14
and TLR2 knockout mice [5,16,62–66]. However, in each of these
cases, differences have been attributed, at least in part, to the much
higher bacterial burdens (up to 1–2 log more organisms) found in
the knockout mice—consistent with the important role of TLRs in
controlling bacterial infection. In the case of CD14 deficient mice,
an additional role for CD14 in controlling p38 MAPK and
negative regulators of inflammation such as suppressors of
cytokine signaling (SOCS) have been suggested to mediate
inflammation through tolerance [66]. The differences in bacterial
burden, although statistically significant, are much smaller in
Nod2 knockout mice and are in opposition to what is seen with
TLR2, CD14 or MyD88 deficiency in that there is a decrease in
bacterial numbers. As such, a role of Nod2 in controlling bacterial
burden seems unlikely to explain differences between in vitro and in
vivo studies.
Figure 10. Prolonged activation of Nod2 induces tolerance to B. burgdorferi. Activated BMDM from wild type (B6) and Nod2 deficient mice
were stimulated with MDP at 100 mg/ml 24 hours prior to stimulation with B. burgdorferi at an MOI 10. Just prior to infection, cells were washed in
DMEM containing 10% FBS and replaced with fresh media. Supernatants were collected 6 hours post B. burgdorferi infection and TNF-a (A) and IL-6
(B) levels were measured by ELISA. For each experiment, the control value was set at 100%. Bars represent mean percent secretion relative to control
cells 6 s.e.m. of three independent experiments. Values for wild type (B6), B. burgdorferi stimulated cells (Bb), in the absence of MDP prestimulation
(-MDP), for each experiment were normalized to 100% and other values are shown relative to B6, –MDP, Bb. Because of the normalization, the s.e.m.
for B6, –MDP, Bb is zero and no error bars are visible, * p,0.05. Non-MDP pretreated wild type cells secreted a mean of 420 pg/ml and Nod2 deficient
cells secreted a mean of 280 pg/ml of IL-6. MDP pre-treated wild type cells secreted a mean of 40 pg/ml and pre-treated Nod2 deficient cells secreted
a mean of 310 pg/ml of IL-6. C) il-10 transcripts were measured by quantitative RT-qPCR, *=p,0.05.
doi:10.1371/journal.pone.0017414.g010
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results in increased inflammation in the different systems have
been suggested including: a role for Nod2 in the induction of the
anti-inflammatory cytokine, IL-10 [48]; a role of Nod2 in the
induction of defensins to control bacterial burden [17,26]; a role of
Nod2 in inhibiting processing and secretion of IL-1b [67]; and the
role of Nod2 in mediating tolerance by attenuating inflammatory
responses initiated by other receptors [32,54]. We examined each
of these mechanisms in our B. burgdorferi model. Both in vitro and in
vivo experiments showed no significant effect of Nod2 deficiency on
the decrease of IL-10 induction in response to B. burgdorferi.
Induction of defensins was actually increased in the Nod2 deficient
mice, which is consistent with the fact that B. burgdorferi numbers
were actually lower in Nod2 deficient mice. Finally, in our in vitro
data using B. burgdorferi as a stimulus, we were not able to detect
secretion of IL-1b and transcription of pro- IL-1b was reduced in
Nod2 deficient cells (Figure 4A,C) rendering it unlikely that Nod2
deficiency leads to increased IL-1b secretion.
The concept that Nod2 may mediate tolerance to stimulation of
other receptors such as TLRs has recently been proposed.
Administration of the Nod2 synthetic ligand, MDP, attenuates
trinitrobenzene sulfonic acid (TNBS) or dextran sodium sulfate
(DSS) induced colitis through the down-regulation of several TLR
responses [68]. Additionally, Hedl et al. have shown in vitro that
prior Nod2 activation, mimicking prolonged infection, is capable
of inducing tolerance to TLR ligands [32,54]. Using a similar in
vitro model as Hedl et al., we were able to show that specific Nod2
stimulation of BMDM with MDP before B. burgdorferi infection
induces partial tolerance to B. burgdorferi in vitro, resulting in the
reduction of inflammatory cytokine production and reversing the
Nod2 deficiency phenotype seen in acute stimulation of cells with
B. burgdorferi. In the absence of Nod2, MDP is not able to induce
tolerance and Nod2 deficient cells secreted more pro-inflamma-
tory cytokines in response to B. burgdorferi than wild type cells.
These results correlated with our observations in vivo where we
found increased inflammatory responses in the joints of Nod2
deficient mice infected with B. burgdorferi compared with wild type
mice.
It is tempting to hypothesize that the differences seen in the role
of Nod2 signaling in the inflammatory response to different
infections may be related to the ‘‘chronicity’’ of the infection. In
this model, Nod2 is a positive regulator of inflammation during the
early stages of infection. However, after a period of sustained
stimulation, the role of Nod2 switches and it becomes a negative
regulator of inflammation, potentially via the induction of
tolerance to further microbial stimulation through either Nod2
itself or other microbial receptors, such as TLRs. Resistance,
which clears the invading organisms, and tolerance, which
Figure 11. Nod2-mediated tolerance affects ifn-a, cxcl10, but not ifit1 and igtp mRNA. Activated BMDM from wild type (B6) and Nod2
deficient mice were treated with MDP at 100 mg/ml 24 hours prior to stimulation to B. burgdorferi at an MOI 10. Just prior to infection, cells were
washed in DMEM containing 10% FBS and fresh media was added. Cells were collected 16 hours post-infection for inf-a (A) and 6 hours post-
infection for cxcl10 (B), igtp (C) and ifit1 (D). mRNA expression was measured by RT-qPCR. Bars represent mean percent change 6 s.e.m. of three
independent experiments, * p,0.05.
doi:10.1371/journal.pone.0017414.g011
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been recognized as separate defense strategies in microbial
defense. It is possible that molecules such as Nod2 can play roles
in both resistance and tolerance during the course of infection.
Tolerance may have as important a role for survival of the host as
resistance, particularly for prolonged infections such as B.
burgdorferi where animals are able to co-exist with the bacteria for
prolonged periods of time by reducing negative inflammatory
reactions. Support for a dual role for Nod2 can be found by
comparing acute versus long-term or chronic infection and
inflammation in Nod2 deficient mice. Most studies evaluating
the role of Nod2 in infection have been done with pathogens that
cause acute infection, such as Listeria, Salmonella, Staphylococcus
[17,57,60,61]. In these cases, Nod2 deficiency results in decreased
pro-inflammatory cytokine levels leading to the reduction of
inflammation in response to pathogen infection. Tolerance may
not be seen in these infections because the infection resolves or the
animal dies after a short period of time. In studies with
Mycobacterium tuberculosis, a pathogen that establishes long-term
infection, Nod2 deficient mice showed decreased pro-inflamma-
tory cytokine production in early stages of infection similar to what
is seen with bacteria causing acute infection [23]. However, later
in the course of infection, Nod2 deficient mice are more prone to
succumb to M. tuberculosis infection and die and exhibit increased
inflammation in histology sections in comparison to wild type mice
[23]. The authors of this study did not propose a mechanism for
the late increase in inflammatory responses. In a model where
arthritis is induced via a single injection of peptidoglycan, Nod2
deficiency results in decreased inflammation [20]. In contrast, in B.
burgdorferi-induced arthritis, Nod2 deficiency increases inflamma-
tion. While there are numerous differences between these models
that could explain why Nod2 could play opposite roles, one
obvious difference is in the kinetics of arthritis development. B.
burgdorferi establishes infection at a distant injection site and then
disseminates to the joints and multiplies over weeks to months,
providing ongoing stimulus, in contrast to the single injection of
peptidoglycan.
In light of recent data showing the role of Nod2 in inducing
tolerance to bacterial ligands in vitro and the data in this report
showing the in vivo results of Nod2 deficiency in a slowly
progressing arthritis, we believe that a model of differing roles of
Nod2 in early and prolonged infection is a likely mechanism to
reconcile opposing studies on the role of Nod2 in inflammatory
responses. Of note, in murine models of B. burgdorferi infection,
arthritis eventually resolves despite persistence of the bacteria in
the joints. While some of the decrease in inflammation is likely
mediated by improved control of bacterial burden over time, host
immune systems also utilize mechanisms for regulating inflamma-
tion after the initial response in order to limit damage to tissues.
Our data supports Nod2 as one of the negative regulators of
inflammation in the murine B. burgdorferi infection model.
The timing of the change of Nod2 from a stimulatory receptor
to an inhibitory receptor in sustained stages of activation and the
signaling pathways that control this switch are not known. Some in
vitro studies have suggested that Nod2 may mediate tolerance by
dampening TLR signaling through down regulation of the IRAK-
1 kinase and perhaps up regulating the negative regulator of TLR
signaling IRAK-M or through negative regulation on TLR
signaling mediated by enhanced activation of IRF4 [32,68].
Recently, a study has shown that Nod2-mediated tolerance is
dependent on Nod2 activation of the mTOR pathway and the
early secretion of anti-inflammatory mediators IL-10, TGF-b and
IL-1Ra [54]. Future studies will be needed to determine the
specific pathways involved in control of B. burgdorferi mediated
arthritis in mice. A more detailed analysis of the regulation of
molecules involved in the Nod2 signaling pathway in chronic
inflammatory states may reveal important additional molecules
and mechanisms that participate in the regulation of signaling
during prolonged periods of Nod2 stimulation.
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